Nephelometric measurement of serum free light chains in nonsecretory myeloma.

被引：0
|
作者：
Mead, GP
Stubbs, PS
Carr-Smith, HD
Drew, RL
Bradwell, AR
机构：
[1] Binding Site Ltd, Birmingham B29 6AT, W Midlands, England
[2] Univ Birmingham, Dept Immunol, Birmingham B15 2TJ, W Midlands, England
来源：
CLINICAL CHEMISTRY | 2002年 / 48卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
A70
引用
收藏
页码：A23 / A23
页数：1
相关论文
共 50 条
  • [41] Clinical usefulness of serum free light chains measurement in patients with multiple myeloma: comparative analysis of two different tests
    Kubicki, Tadeusz
    Dytfeld, Dominik
    Baszczuk, Aleksandra
    Wysocka, Ewa
    Komarnicki, Mieczyslaw
    Lewandowski, Krzysztof
    [J]. POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2017, 71 : 40 - 46
  • [42] RECOMMENDATIONS FOR SERUM FREE LIGHT CHAINS (SFLC) MEASUREMENT IN ROUTINE LABORATORIES
    Tate, Jill
    Jovanovich, Sue
    Mollee, Peter
    Chiu, Weldon
    Wienholt, Louise
    Gillis, David
    Reibelt, Lindsay
    Youdell, Odette
    [J]. INTERNAL MEDICINE JOURNAL, 2014, 44 : 28 - 28
  • [43] Evaluation of the performance of SPAPLUS system for the measurement of free light chains in serum
    Infusino, Ilenia
    Dolci, Alberto
    Panteghini, Mauro
    [J]. BIOCHIMICA CLINICA, 2013, 37 (05) : 370 - 375
  • [44] Prediction of Response and Progression in Multiple Myeloma With Serum Free Light Chains Assay: Corroboration of the Serum Free Light Chain Response Definitions
    Khoriaty, Rami
    Hussein, Mohamad A.
    Faiman, Beth
    Kelly, Megan
    Kalaycio, Matt
    Baz, Rachid
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (01): : E10 - E13
  • [45] EXTRAORDINARY APPEARANCE OF MOTT-CELLS IN A NONSECRETORY AND AN OLIGOSECRETORY MYELOMA WITH KAPPA-LIGHT CHAINS
    BAIER, J
    GUTSCH, J
    FIRUSIAN, N
    [J]. TUMORDIAGNOSTIK & THERAPIE, 1994, 15 (05) : 203 - 206
  • [46] The Relationship Between Serum Free Light Chain Levels and Serum Immunofixation Electrophoresis: Implications for the Definition of "Stringent CR" in Myeloma.
    Allen, S.
    Vickrey, E.
    Mehta, J.
    Singhal, S.
    [J]. BLOOD, 2008, 112 (11) : 941 - 941
  • [47] PROGNOSTIC CONTRIBUTION OF UNINVOLVED SERUM FREE LIGHT CHAINS (USFLC) IN MULTIPLE MYELOMA (MM)
    Koulieris, E.
    Maltezas, D.
    Tzenou, T.
    Kafassi, N.
    Bartzis, V.
    Bitsanis, K.
    Efthymiou, A.
    Vardounioti, I.
    Karali, V.
    Nikolaou, E.
    Dimou, M.
    Tsaftaridis, P.
    Angelopoulou, M.
    Panayiotidis, P.
    Pangalis, G.
    Kyrtsonis, M.
    [J]. HAEMATOLOGICA, 2012, 97 : 601 - 601
  • [48] EVALUATION OF FREE LIGHT CHAINS (FLC) IN SERUM AND BONE MARROW IN PATIENTS WITH MULTIPLE MYELOMA
    Pizzuti, M.
    Chitarrelli, I.
    Smaldore, G.
    Girardi, A.
    Penitente, R.
    Pascale, S. P.
    Nuccorini, R.
    Coluzzi, S.
    Matturro, A.
    Attolico, I.
    Amendola, A.
    Cimminiello, M.
    Filardi, N.
    Vertone, D.
    [J]. HAEMATOLOGICA, 2016, 101 : S112 - S113
  • [49] Light chain myeloma: Correlation of serum nephelometric analysis for the quantitation of immunoglobulin free light chain with urine Bence Jones protein.
    Abraham, RS
    Katzmann, JA
    Clark, RJ
    Lymp, JF
    Dispenzieri, A
    Lust, JA
    Bradwell, AR
    Kyle, RA
    [J]. CLINICAL CHEMISTRY, 2001, 47 (06) : A33 - A33
  • [50] Nonsecretory plasma cell myeloma - Becoming even more rare with serum free light-chain assay - A brief review
    Shaw, Gene R.
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2006, 130 (08) : 1212 - 1215
12345